RVTY
REVVITY, INC.
+3.56 (+2.44%)149.29USD1.0M成交股數16.7B市值71.4本益比(近四季)5.7股價營收比+1.3%營收年增(近四季)2026-10-26下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 730M+10% | 711M-3% | 699M+2% | 720M+4% | 665M+2% | 729M+9% | 684M-4% | 692M+2% | 650M | 671M | 709M | 675M |
| 營業成本 | 313M | 323M | 324M | 328M | 289M | – | 299M | 306M | 295M | 298M | 307M | 293M |
| 毛利 | 417M+11% | 388M | 375M-3% | 393M+2% | 376M+6% | – | 385M-4% | 386M+1% | 355M | 373M | 402M | 381M |
| 毛利率 | 57.1% | 54.5% | 53.6% | 54.5% | 56.5% | – | 56.3% | 55.7% | 54.6% | 55.5% | 56.7% | 56.5% |
| 研發費用 | 49.0M | 57.9M | 50.8M | 53.3M | 53.6M | 49.2M | 49.1M | 48.1M | 50.4M | 53.0M | 57.3M | 56.7M |
| 銷售管理費用 | 279M | 254M | 242M | 249M | 250M | 244M | 238M | 252M | 261M | 250M | 267M | 249M |
| 營業利益 | 89.3M+24% | 75.9M-36% | 81.9M-17% | 90.8M+6% | 72.2M+64% | 119M+72% | 98.2M+26% | 85.7M+13% | 44.1M | 69.2M | 78.1M | 76.1M |
| 營業利益率 | 12.2% | 10.7% | 11.7% | 12.6% | 10.9% | 16.3% | 14.3% | 12.4% | 6.8% | 10.3% | 11.0% | 11.3% |
| 稅後淨利 | 51.8M+23% | 40.7M-57% | 46.7M-51% | 53.9M-3% | 42.2M+62% | 94.6M+897% | 94.4M+165% | 55.4M-90% | 26.0M | 9.5M | 35.6M | 569M |
| 淨利率 | 7.1% | 5.7% | 6.7% | 7.5% | 6.4% | 13.0% | 13.8% | 8.0% | 4.0% | 1.4% | 5.0% | 84.4% |
| 稀釋 EPS | 0.47+34% | 0.36-53% | 0.40-48% | 0.46+2% | 0.35+67% | 0.77+863% | 0.77+175% | 0.45-90% | 0.21 | 0.08 | 0.28 | 4.50 |
| 稀釋股數 | 112M | 112M | 115M | 118M | 120M | 123M | 123M | 123M | 124M | 124M | 125M | 126M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.0B | 860M | 931M | 992M | 1.1B | 1.2B | 1.2B | 1.2B | 998M | 1.1B | 1.3B | 2.3B |
| 應收帳款 | 709M | 691M | 680M | 661M | 617M | 632M | 602M | 597M | 589M | 645M | 627M | 587M |
| 存貨 | 379M | 388M | 380M | 388M | 381M | 368M | 405M | 401M | 414M | 436M | 437M | 429M |
| 總資產 | 12.0B | 12.0B | 12.1B | 12.4B | 12.4B | 12.4B | 12.8B | 13.4B | 13.4B | 13.4B | 14.2B | 14.6B |
| 有息負債 | 2.6B | 2.6B | 2.6B | 3.2B | 3.2B | 3.2B | 3.2B | 3.2B | 3.2B | 3.2B | 3.9B | 3.9B |
| 總負債 | 4.8B | 4.8B | 4.8B | 4.8B | 4.7B | 4.7B | 4.8B | 5.6B | 5.6B | 5.7B | 6.3B | 6.6B |
| 股東權益 | 7.2B | 7.2B | 7.4B | 7.6B | 7.6B | 7.7B | 7.9B | 7.9B | 7.8B | 7.7B | 7.9B | 8.0B |
| 負債比 | 40.0% | 40.1% | 39.2% | 38.9% | 38.2% | 38.1% | 38.0% | 41.4% | 41.6% | 42.7% | 44.7% | 45.1% |
| 淨現金(現金 − 有息負債) | −1.6B | −1.8B | −1.7B | −2.2B | −2.0B | −2.0B | −2.0B | −1.9B | −2.2B | −2.0B | −2.6B | −1.6B |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 115M | – | – | 128M-13% | – | – | – | 148M | – | – | 63.5M |
| 資本支出 | – | 19.8M | – | – | 16.0M | – | – | – | 17.8M | – | – | 20.9M |
| 自由現金流 | – | 95.5M | – | – | 112M-14% | – | – | – | 130M | – | – | 42.5M |
| 折舊攤銷 | – | 105M | – | – | 97.4M | – | – | – | 108M | – | – | 109M |
| 買回庫藏股 | – | 86.5M | – | – | 154M | – | – | – | 10.8M | – | – | 61.7M |
| 現金股利 | – | 7.8M | – | – | 8.4M | – | – | – | 8.6M | – | – | 8.8M |
| 自由現金流率 | – | 13.4% | – | – | 16.9% | – | – | – | 20.0% | – | – | 6.3% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 2.9B
| Life Sciences | 1.4B | 50.1% | +2.3% |
|---|---|---|---|
| Diagnostics | 1.4B | 49.9% | +5.1% |
地區2025 年度 · 2.3B
| 歐洲 | 825M | 35.4% | +11.1% |
|---|---|---|---|
| 亞洲 | 775M | 33.3% | -1.8% |
| 中國 | 425M | 18.2% | -5.5% |
| 德國 | 178M | 7.6% | +9.3% |
| 英國 | 127M | 5.4% | +12.4% |
| Total International 小計 | 1.7B | 74.3% | +4.4% |
| 美洲 小計 | 1.3B | 53.9% | +2.7% |
| 美國 小計 | 1.1B | 48.3% | +2.6% |
| Other International 小計 | 1.0B | 42.9% | +7.4% |
產品／服務2025 年度 · 2.9B
| 產品 | 2.4B | 83.7% | +2.2% |
|---|---|---|---|
| 服務 | 466M | 16.3% | +11.8% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.9B | +3.7% | 241M | 8.4% | 2.07 | 509M |
| FY2024 | 2.8B | +0.2% | 270M | 9.8% | 2.20 | 542M |
| FY2023 | 2.8B | -16.9% | 693M | 25.2% | 5.55 | 9.9M |
| FY2023 | 3.3B | -13.5% | 569M | 17.2% | 4.50 | 594M |
| FY2022 | 3.8B | +43.7% | 943M | 24.6% | 8.08 | 1.3B |
| FY2021 | 2.7B | -7.6% | 728M | 27.3% | 6.49 | 829M |
| FY2019 | 2.9B | +3.8% | 228M | 7.9% | 2.04 | 287M |
| FY2018 | 2.8B | – | 238M | 8.6% | 2.13 | 218M |